ReviewJournal of inflammation research2026
Autophagy-Ferroptosis Interplay Network: Redefining Therapeutic Paradigms for Diabetic Wound Healing.
Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic wounds are clinically challenging due to poor healing and the potential for amputation in advanced cases. The roles of autophagy and ferroptosis, two pivotal regulators of cell fate, in diabetic wound healing have drawn increasing attention. However, a comprehensive review synthesizing their crosstalk in this context is lacking. This review addresses a central paradox: within the diabetic wound microenvironment, autophagy can either inhibit or promote ferroptosis, depending on the context. Integration of current evidence reveals that this paradox arises from the intricate coupling of autophagy and ferroptosis at key molecular nodes, including the p62-Keap1-Nrf2 axis, the NCOA4-mediated ferritinophagy axis, and a lipid-peroxide-driven feedback loop. The diabetic milieu, characterized by hyperglycemia, oxidative stress, and chronic inflammation, systemically disrupts the balance of this interactive network. This results in a self-reinforcing pathological state that drives cellular death, prolongs inflammation, and hinders tissue repair. This network imbalance is considered a critical molecular foundation of impaired diabetic wound healing. Consequently, we argue that therapeutic strategies must undergo a paradigm shift from single-target interventions toward multi-target, spatiotemporally specific modulation of network nodes. We systematically evaluate integrated pharmacological, bioengineering, and biophysical approaches to achieve this goal. However, it is important to acknowledge that the proposed framework is predominantly based on preclinical evidence, and its clinical translation warrants further validation. Despite this limitation, the integrative framework presented herein deepens the understanding of diabetic wound pathophysiology and provides a theoretical foundation for precision therapy in diabetic wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.